Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Avacopan

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 166,094Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vifor's Tavneos (avacopan) Receives Approval in Europe
    Vifor's Tavneos (avacopan) Receives Approval in Europe

    19 Jul 2023

    // EMA

    https://www.ema.europa.eu/en/documents/overview/tavneos-epar-medicine-overview_en.pdf

    EMA
    19 Jul 2023
    Share Share
    Tavneos included in updated EULAR recommendations for the management of AAV
    Tavneos included in updated EULAR recommendations for the management of AAV

    27 Mar 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tavneos-avacopan-included-in-updated-eular-recommendations-for-the-management-of-aav-301782385.html

    PR NEWSWIRE
    27 Mar 2023
    Share Share
    Vifor Pharma's Tavneos (Avacopan) Approved In Europe
    Vifor Pharma's Tavneos (Avacopan) Approved In Europe

    13 Feb 2023

    // EMA

    https://www.ema.europa.eu/en/documents/overview/tavneos-epar-medicine-overview_en.pdf

    EMA
    13 Feb 2023
    Share Share
    Vifor's Tavneos (Avacopan) Receives Approval in the Europe
    Vifor's Tavneos (Avacopan) Receives Approval in the Europe

    25 Nov 2022

    // EMA

    https://www.ema.europa.eu/en/documents/overview/tavneos-epar-medicine-overview_en.pdf

    EMA
    25 Nov 2022
    Share Share
    ChemoCentryx Announces TAVNEOS Presentations at Upcoming Medical Conferences
    ChemoCentryx Announces TAVNEOS Presentations at Upcoming Medical Conferences

    24 Aug 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/08/24/2503784/19219/en/ChemoCentryx-Announces-TAVNEOS-avacopan-Presentations-at-Upcoming-Medical-Conferences.html

    GLOBENEWSWIRE
    24 Aug 2022
    Share Share
    Tavneos recommended by England’s NICE for the treatment of AAV (GPA/MPA)
    Tavneos recommended by England’s NICE for the treatment of AAV (GPA/MPA)

    17 Aug 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220817005538/en

    BUSINESSWIRE
    17 Aug 2022
    Share Share